Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Live patents
- 3
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 5 human prescription drug, 1 drug for further processing. By marketing category: NDA 5, DRUG FOR FURTHER PROCESSING 1.
| Dosage form | NDCs |
|---|---|
| insert | 2 |
| kit | 2 |
| ring | 2 |
| Route | NDCs |
|---|---|
| vaginal | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| millicent us, inc. | 6 |
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8629129 | INTRAROSAprasterone | product | Aug 2028 |
| 8957054 | INTRAROSAprasterone | use | Jan 2030 |
| 8268806 | INTRAROSAprasterone | product | Mar 2031 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FEMLYV | Norethindrone Acetate/Ethinyl Estradiol | kit | 72495-601NDA |
| Femring | estradiol acetate | ring, vaginal | 72495-201NDA |
| Femring | estradiol acetate | ring, vaginal | 72495-202NDA |
| Intrarosa | Prasterone | insert, vaginal | 72495-401NDA |
| Intrarosa | Prasterone | insert, vaginal | 72495-501NDA |
| - | norethindrone acetate/ethinyl estradiol | kit | 72495-600DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing prasterone
- Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.1 site · 11 NDC
Enquiry
Common questions
- Is Millicent US, Inc. FDA approved?
- Millicent US, Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Millicent US, Inc. make?
- 6 products are listed under Millicent US, Inc. in the openFDA NDC Directory, most often as insert; kit; ring. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.